Key result
Exposure to first- or second-generation antipsychotics increased the risk of venous thromboembolism and pulmonary embolism compared to non-use.
Why the study?
Clinical studies have yielded inconsistent results regarding whether antipsychotic use increases the risk of thromboembolism.
Does antipsychotic exposure increase the risk of venous thromboembolism and pulmonary embolism?
Meta-Analysis (n=31,514,226)
Does antipsychotic exposure increase the risk of venous thromboembolism and pulmonary embolism?
The use of antipsychotics is associated with an increased risk of venous thromboembolism and pulmonary embolism, with risk varying by drug type and patient characteristics such as age and obesity.
Answers are grounded in this paper and cite their sources.
Antipsychotic exposure was associated with higher VTE/PE risk; leaves open whether this supports routine prophylaxis or monitoring in high-risk patients.
BACKGROUND: Different clinical studies have given inconsistent results on whether the use of antipsychotics increases the risk of thromboembolism. In this paper, we reviewed all relevant literature to provide suggestions for clinical diagnosis and treatment. METHODS: PubMed, Web of Science, EMBASE, MEDLINE, Cochrane and Scopus databases were thoroughly searched up to June 2019. Two researchers independently searched the literature, extracted data. Data were analyzed by Stata 12.0 software. RESULTS: A total of 22 studies involving 31514226 subjects were included. This meta-analysis showed that patients taking the first- or second-generation antipsychotics had a higher risk of venous thromboembolism and pulmonary embolism than those who did not, and low potency first-generation agents increased the risk of venous thromboembolism more than high potency antipsychotics, and olanzapine, clozapine, haloperidol, perphenazine and risperidone also significantly increased the risk of it. The risk of venous thrombosis in obese people was higher than that in overweight people, patients not less than 65 years old had an increased risk compared with younger patients. In addition, women taking antipsychotics had a higher risk of pulmonary embolism than men. CONCLUSION: The use of antipsychotics will increase the risk of venous thromboembolism and pulmonary embolism, which will be affected by the type of antipsychotics and patient characteristics.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2020) conducted a meta-analysis in Venous thromboembolism and pulmonary embolism (n=31,514,226). Antipsychotics vs. No antipsychotics was evaluated on Risk of venous thromboembolism and pulmonary embolism. Exposure to first- or second-generation antipsychotics increased the risk of venous thromboembolism and pulmonary embolism compared to non-use.
Synapse has enriched 10 related papers. Consider them for comparative context: